ASNR Study Groups

ASNR members may join any of our Study Groups when joining or renewing membership. Contact membership@asnr.org for more information.

Chair: Rajan Jain, MD
This study group was created for the purposes of facilitating the exchange of information and knowledge amongst experts and fostering collaborative research that will propel neuroradiology in the next phase of its evolution, ensuring that neuroradiologists will provide the best possible care to their patients. The group will bring hot topics and experts from academia, private practice, and industry to brainstorm ideas about research and clinical implementation of latest AI tools and techniques. This study group is a great
place for younger members to get involved with AI related activities sponsored by ASNR and ASFNR, including the annual AI Workshop.

Co-Chairs: Tammie Benzinger, MD, PhD; Clifford Jack, MD
Vice Chair: Petrice Cogswell, MD, PhD
This group was created to facilitate the exchange of information in the field of Alzheimer’s Disease and Dementia, with a specific interest in sharing information about the diagnosis, treatment, and research of amyloid-related imaging abnormalities (ARIA). More information is available on the Alzheimer’s Resources page.

Co-Chairs: Bruce Wasserman, MD; David Saloner, MD
The goal of this study group is to advance our understanding of cerebrovascular diseases by developing and support vessel wall imaging protocols and clinical/translational studies. Objectives include:

  • Develop uniform protocols for clinical implementation and reimbursement.
  • Stimulate research in the field, including multicenter investigations of the pathophysiology and risk factors of neurovascular disease.
  • Attract people with similar interests in vessel wall imaging from around the world.
  • Promote education and teaching mechanisms in the field, and present a unified voice for achieving vendor support for protocol development.

Co-Chairs: Vince Kumar, MD; Michael Zeineh, MD-PhD
The goal of this study group is to facilitate the exchange of information and knowledge amongst experts and foster collaborative research in functional and diffusion MRI.

Co-Chairs: Camilla Lindan, MD; P. Ellen Grant, MD, MSc, FACR; Christopher Hess, MD, PhD
The purpose of this group is to:

  • Inform and educate the Diagnostic and Interventional Neuroradiology community about advances in genetic and cellular therapies for the treatment of neurologic disease.
  • Cultivate thought leadership in imaging and image-guided delivery of gene-modifying and cellular therapies.
  • Strengthen collaboration with clinical and industry colleagues to design and implement trials, develop new technologies and implement clinical standards of care for gene-modifying and cellular
    therapies.

Chair: Bhavya Shah, MD
Vice Chair: Tim Kaufmann, MD
MR Guided Focused Ultrasound (FUS) is a dynamic, nascent technology that is FDA approved as an alternative to surgery for movement disorders. Targeted blood brain barrier opening and low intensity focused ultrasound neuromodulation also hold substantial promise for treating CNS diseases. This ASNR workgroup will lead efforts to advance and strengthen brain FUS efforts.

Co-Chairs: Ramon Barajas, MD; Jana Ivandize, MD, PhD
This study group focuses on the application of PET-guided diagnosis and treatment of primary and metastatic brain tumors, attempting to identify further areas of exploration and multi-society collaboration for the establishment of consensus imaging guidelines, novel translational radiotracer development, and reimbursement advocacy; with a patient centered emphasis. Objectives include:

  • Connect study group members with current evidence for clinical utility of validated radiotracers and opportunities for improved brain tumor extent delineation, treatment planning and response assessment.
  • Leverage member knowledge and expertise toward translational advancement of novel radiotracers.
  • Provide current evidence and clinical limitations of theranostic approaches with an emphasis on collaborative multi-societal drafting of multi-specialty consensus guidelines regarding applications of PET in Neuro-Oncology.
  • Undertake reimbursement advocacy for clinically useful PET radiotracers and theranostic agents.

Co-Chairs: Erik Middlebrooks, MD; Jun Hua, MD
Vice Chairs: Daniel Paech, MD; Marta Bianciardi, PhD
The Ultra-High Field MRI Study Group is dedicated to advancing the clinical application of ultra-high field MRI, particularly 7T MRI, in diagnostic neuroradiology. Our mission is to:

  • Promote the dissemination of cutting-edge knowledge on the advancements and clinical utility of 7T MRI.
  • Develop and recommend evidence-based clinical guidelines and best practices for the use of 7T MRI in neuroradiology.
  • Foster collaboration between clinical neuroradiologists, physicists, and MRI scientists to accelerate the integration of emerging technologies into clinical practice.
  • Establish and standardize advanced imaging techniques and protocols to enhance diagnostic accuracy and patient outcomes across diverse clinical settings.